Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

It may not sound surprising that treating obesity in adolescents and teens may have positive mental health impacts, but ...

Further, the company expected the market to grow significantly in the coming years. Further, the company is also developing ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Mintel, the experts in what consumers want and why, has today announced four key trends that will shape the global food and drink industry in the years ahead. In 2025 and beyond, expect to see GLP-1 ...

The FDA yesterday the approval of Novocure’s Optune device to include the treatment of metastatic non-small cell lung cancer.

Researchers found that 1.4% of adolescents on weight loss medications had a suicide attempt or ideation, compared with 2.3% of children who weren’t taking the medicines. Separately, anxiety is found ...